Tag:
Yaupo Therapeutics
Latest Headlines
Latest Headlines
VC groups proffer $14.4M to back Yaupon's lymphoma drug app
Yaupon Therapeutics has rounded up $14.4 million in venture capital in a Series D round designed to get the biotech company through the New Drug Application process for its gel therapy for lymphoma.
